Concepedia

Cheryl Brink

CB

Statistics

Publications

1

Citations

87

H-Index

1

Active since

2006

Affiliations

Southern Research Institute(Current)

Cheryl Brink is an author at Southern Research Institute specializing in tumor progression, malignant neoplasms, and lung cancer.

Publications per year

2006–2006

1

Publications

1

Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma

Christopher A. Carter, Charles Chen, Cheryl Brink et al. · Cancer Chemotherapy and Pharmacology · 2006 · 87 citations

Medicine, Oncology, Pharmacology +10

1–1 of 1